From Bioblast
Revision as of 09:33, 30 September 2021 by Beno Marija (talk | contribs) (Created page with "{{O2k-Network Lab |institution=Hemenway at University of Kansas Medical Center, Department of Neurology, University of Kansas Alzheimer’s Disease Center |address=2106 Ol...")
US KS Kansas City Wilkins H
| O2k-Network Lab | Hemenway at University of Kansas Medical Center,
Department of Neurology, University of Kansas Alzheimer’s Disease Center |
|---|---|
| Address | 2106 Olathe Blvd Bldg 64 Room 1039, 66109 |
| City | Kansas City |
| State/Prov | Kansas (KS) |
| Country | USA |
| Weblink | |
| Contact | Wilkins Heather M |
| Team | |
| Team previous | |
| Status | O2k 2019- |
| Oroboros Events | |
| Topics |
O2k-Publications
| Published | Reference | |
|---|---|---|
| Taylor 2024 Pilot Feasibility Stud | 2024 | Taylor MK, Burns JM, Choi IY, Herda TJ, Lee P, Smith AN, Sullivan DK, Swerdlow RH, Wilkins HM (2024) Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer's disease. Pilot Feasibility Stud 10:42. https://doi.org/10.1186/s40814-024-01469-5 |
| Tungtur 2021 Sci Rep | 2021 | Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Sci Rep 11:11051. |
O2k-Abstracts
update please
